CME Group director Siegel proposes $606K share sale
The shares are being sold from Howard J. Siegel Revocable Trust U/A 6/12/12 and were acquired through stock awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CME Group Inc. director Howard J. Siegel reported a proposed sale of 2,000 common shares, with an approximate sale date of November 2, 2026. The shares are being sold from the Howard J. Siegel Revocable Trust U/A 6/12/12 through Fidelity Brokerage Services LLC; their reported aggregate market value is $606,004.20. The shares were acquired through stock awards: 879 shares dated June 25, 2025, and 1,121 shares dated June 27, 2022.
Key Figures
Key Terms
Rule 144 regulatory
stock award financial
revocable trust regulatory
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.